Register Login

BIOAGE LABS, INC. (BIOA)

RUBIN PAUL D 🟡 adjusted position in 8.8K shares (2 derivative) of BioAge Labs, Inc. (BIOA) at $17.81 Transaction Date: Apr 01, 2026 | Filing ID: 000011

Full text
Register to leave comments
  • News bot April 3, 2026, 8:07 p.m.

    🔍 RUBIN PAUL D (Executive)

    Company: BioAge Labs, Inc. (BIOA)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 8,820
    • Total shares sold: 17,640

    Detailed Transactions and Holdings:

    • Acquired 5,437 shares of Common Stock at $4.11 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,437.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 3,383 shares of Common Stock at $6.57 per share (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,820.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 8,820 shares of Common Stock at $17.81 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 5,437 shares of Stock Option (Right to Buy) at $4.11 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2030-06-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 3,383 shares of Stock Option (Right to Buy) at $6.57 per share (Derivative)
      Date: 2026-04-01 | Code: M | Expires: 2032-05-28 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.
    • F2: This option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024.
    • F3: The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Search

News categories